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Abstract 
Whole genome sequencing (WGS) has the potential to revolutionize the diagnosis of 
Mycobacterium tuberculosis (MTB) but the lack of bioinformatic expertise among clinical 
microbiologists is a barrier for adoption. Software products for analysis should be simple, free of 
charge, able to accept data directly from the sequencer (FASTQ files) and to provide the basic 
functionalities all-in-one.  
The main aim of this narrative review is to provide a practical guide for the clinical 
microbiologist, with little or no practical experience of WGS analysis, with a specific focus on 
software products tailored made for MTB analysis. 
With sequencing performed by an external provider, it is now feasible to implement WGS 
analysis in the routine clinical practice of any microbiology laboratory, with the potential to detect 
resistances weeks before traditional phenotypic culture methods, but the clinical microbiologist 
should be aware of some major limitations. 
 
Introduction 
Tuberculosis (TB) still remains a global health problem1. Identification and susceptibility testing 
with conventional culture methods can take up to eight weeks for the final report2, whilst 
targeted molecular tests (e.g. Xpert MTB/RIF and other PCR based methods), although much 
more rapid, only examine a limited number of target regions3. Whole genome sequencing 
(WGS) has been shown to provide a rapid and comprehensive view of the genotype of 
Mycobacterium tuberculosis (MTB), with the potential to reliably predict drug susceptibility within 
a clinically relevant timeframe4. In addition, it provides the highest resolution when investigating 
outbreaks5.  
However, the lack of bioinformatic expertise among clinical microbiologists is a potential barrier 
for clinical adoption. The Wellcome Trust Sanger Institute (UK)6, the Galaxy project7 
(Pennsylvania State and John Hopkins universities - USA) and the Broad Institute8 
(Massachusetts Institute of Technology and Harvard University - USA), all combined offer 
hundreds of different software products for the analysis of WGS data but their high number and 
various functionalities often leave the unexperienced user confused in front of such enormous 
choice. It is evident that the use of WGS, despite its great potential, may be hampered by the 
complexity of data and its analysis. Hence, there is a need for simpler software tools, free of 
charge, able to analyze data directly from the initial FASTQ files and to provide the basic 
functionalities all-in-one.  
Thus, the main aim of this narrative review is to provide a guide for the clinical microbiologist, 
with little or no practical experience in WGS analysis, with a specific focus on software products 
tailored made for MTB analysis. It is important to keep in mind that this review is not aimed to be 
a comprehensive, systematic description of all next generation sequencing platforms and 
analytic tools, but we have made the assumption that the sequencing is performed by an 
external provider and a FASTQ file is the end result received.  
Extraction of genomic DNA and sequencing formats 
Extraction of genomic DNA from mycobacteria still requires special consideration because of 
the reduced bacterial load and the difficulty in extraction9. Minimum concentration of genomic 
DNA required is generally 10ng/µl with a 260/280 ratio of at least 1.8 (current requirement at 
Public Health England – PHE), but lower concentration may be accepted depending on the 
library preparation used/provider10. We continue to use the cetyltrimethylammonium bromide 
(CTAB) method11,12,13 and this is best performed from Löwenstein–Jensen culture. Other 
methods are available, including commercial extraction kits14,15. Once the DNA has been 
extracted, quantification needs to be confirmed using a Qubit fluorometer (Thermo Fisher 
Scientific, USA) or other alternative method16 and the sample is now ready to be sent to the 
external provider for the sequencing.  
All output files should be easily downloadable using a FTP (File Transfer Protocol) server (e.g. 
FileZilla software, freely available online under General Public License). Different format files17 
are used (Table 1) and they represent another major limitation in the analysis of WGS data. In 
addition, knowledge of Linux operating system and command line18 is often essential for most of 
the advanced bio-informatics analysis.  
Free online tools available for WGS analysis in MTB 
We have reviewed four software programs focused on the rapid identification and susceptibility 
testing of MTB using WGS technology. As already mentioned, there are numerous software 
products available on the market but only programs available online (or downloadable in one 
click), free of charge, in English language and able to directly analyze raw FASTQ files (without 
any knowledge of Linux command line) were included. An overview of their different 
functionalities is shown in Tables 2 and 3.  
- Mykrobe predictor19 is a software package developed at the Wellcome Trust Centre for 
Human Genetics and collaborators20. The software presents a user friendly graphic 
interface in which raw sequence data in FASTQ format can be uploaded to generate a 
fast report (within 3 minutes), easily interpretable by clinicians. Files can be uploaded 
singularly (upload of paired end reads and multiple data is not allowed) and resistance 
panels and phylogenetic lineages are detected. The main limitation is that it does not 
provide information about sample quality, phylogenetic tree and linkage networks (Table 
2). It detects the majority of first and second line drugs (Table 3). It is the only product 
that can be downloaded on your desktop and used without an internet connection.  
- TB Profiler21 was developed at the London School of Hygiene & Tropical Medicine and it 
processes raw sequence data identifying strain type and known drug resistance markers 
(with a drug resistance library containing 1,325 mutations) 22. Sequence data can be 
submitted as single end or paired end read (FASTQ file) and processing time is under 10 
minutes per sample plus queuing time (variable depending on concurrent demand). The 
displayed output provides information about resistances to 11 TB drugs (Table 3) and 
lineages specific mutations. However, phylogenetic tree and linkage networks are not 
available (Table 2). 
- TGS-TB23, Total Genotyping Solution for Mycobacterium tuberculosis (TGS-TB) is an all-
in-one web based tool developed by Sekizuka et al24. Information about number of 
trimmed map reads and coverage region depth is provided. The resistances target list 
permits detection of genetic alterations for the majority of first and second line drugs 
(Table 3). In addition, up to 10 paired-ends FASTQ files can be uploaded simultaneously 
and the comparison of samples with phylogenetic tree allows outbreak investigation.  
- PhyRes SE25, the Phylo-Resistance Search Engine (PhyResSE)26 is designed to enable 
nonspecialized users to extract phylogenetic and resistance information from WGS data. 
Single end or paired end reads can be freely submitted and multiple file selection for 
upload is supported. A validation process runs to reject improperly formatted data files. 
Rigorous preprocessing and QC at the level of raw data, mapping performance, and 
individual SNPs are unique characteristics of the system. After preprocessing, variants 
are called and provided in VCF format and as HTML table carrying additional information 
about amino acid changes and what is known in terms of association with genotype or 
resistance. The majority of first and second line drugs are detected (Table 3).  
Discussion 
WGS holds great potential for the rapid diagnosis of drug-resistant TB and it does offer some 
added value when compared to traditional susceptibility testing. Phenotypic methods for TB are 
expensive, technically complex and time consuming27. It is current practice to initially test only 
for first line antibiotics (Rifampicin, Isoniazid, Ethambutol, Pyrazinamide, Streptomycin) and to 
subsequently perform second and third line susceptibility testing in case of drug resistance. 
This, combined with possible sample contamination or failure to grow in specific testing media, 
often causes delays of weeks (and even months) before receiving the final susceptibility profile. 
Full WGS diagnostics could theoretically be generated within 9 days (weeks in advance 
comparing to culture) and it could also be 7% cheaper than the present diagnostic workflows28. 
However, a recent report29 from the EUCAST subcommittee on the role of WGS in antimicrobial 
susceptibility testing (AST) of bacteria, concluded that available published evidence is currently 
insufficient and it does not support the use of WGS inferred susceptibility to guide clinical 
decision making. It has also highlighted some specific issues regarding MTB, in particular the 
current discrepancies between genotype and phenotype and the need of large datasets to 
clarify the role of rare resistance mechanisms and the level of resistance conferred by different 
mutations. Also, WGS does not seem to resolve some of the current problems of traditional 
susceptibility testing, in particular Pyrazinamide sensitivity30, and it may actually over-report 
fluoroquinolones resistance in case of rare mutations conferring only higher MIC31 or miss 
hetero-resistance without deep sequencing32. 
Accreditation (ISO 15189 and others) is another possible problem. None of the mentioned 
software tools is actually licensed for clinical/diagnostic use. One exception is the analysis 
infrastructure that is currently being evaluated by Public Health England in Birmingham (UK)33.  
WGS clearly has a role in public health interventions and in the detection of outbreaks and 
transmission events. Several studies confirm this role34,35, and the higher resolution compared to 
MIRU-VNTR typing, IS6110 RFLP typing and spoligotyping methods. Not all the online tools 
considered will be useful for this, with only TGS-TB and PhyResSE allowing phylogenetic trees 
and with TGS-TB also performing more in depth network analysis (including SNPs detection). 
However, several challenges remain before WGS can be routinely used in outbreak 
investigation and clinical practice36, from better integration with conventional epidemiology and 
healthcare informatics systems to the need of moving beyond single-nucleotide polymorphisms 
(SNPs) typing to embrace  full range of genome variation, including within-patient variation. 
Unfortunately, many practical questions (how to deal with phenotype/genotype discrepant 
results, mutations conferring low level of resistance and hetero-resistance) are still unanswered 
and, based on these considerations, WGS is unlikely to completely replace phenotypic AST for 
TB in the near future. The clinical microbiologist should be aware of these limitations but this 
should not prevent the use of WGS.  
This review has summarized the current online software tools available to support the clinical 
microbiologist in the analysis of WGS data in MTB. It is feasible to implement this approach in 
the routine clinical practice of any microbiology laboratory (with sequencing performed by an 
external provider). Not only would this inform individual patient management but could 
contribute to production and comparison of large independent datasets. This is essential if we 





Tables and figures 
File formats used in Whole Genome Sequencing analysis 
FASTQ  FASTQ is the original and predominant file format when receiving WGS data from the 
sequencing provider (or in house analysis using an Illumina platform – Illumina, San 
Diego, USA) and all other formats will have to be created from it using the numerous 
software tools available on the market. The FASTA file is a similar version but without the 
quality metrics. 
SAM/BAM  A SAM (Sequence Alignment Map) file represents a generic format for storing large 
nucleotide sequence alignments. It was created with the objective to obtain a well-defined 
interface between alignment and downstream analyses, including variant detection, 
genotyping and assembly. A BAM file is the binary version (or simply a lighter version) 
and it is easier to be handled with common computers.   
VCF This Variant Call Format was developed by the 1000 Genomes project to encode SNPs 
and other structural genetic variants. It allows representation of a wide variety of genomic 
variation with respect to a single reference sequence. 
SFF Standard Flowgram Format is the equivalent of FASTQ but from other platforms other 
than Illumina. 
Many other files are available (i.e. SRA, GFF, GTF, BED) but they are used for more specialized 
analysis 
Table 1: Most common files used for WGS output formats 
Functionality Mykrobe predictor TB Profiler TGS-TB PhyResSE 
Resistance     
Lineage     
Phylogenetic tree     
Network analysis     
Quality Control     
Time: per sample of 100 
Mb 3 min 5 min 10 min 15 min 
Table 2: Comparison of the functionalities offered by web based software tools for the analysis of whole 
genome sequencing data of Mycobacterium tuberculosis.  
Drug Mykrobe Predictor TB Profiler TGS-TB PhyResSE 
Isoniazid (INH)     
Rifampicin (RIF)     
Pyrazinamide (PZA)     
Ethambutol (EMB)     
Streptomycin (SM)     
 
Fluoroquinolones (FQs)     
Kanamycin (KAN)      
Amikacin (AMK)     
Capreomycin (CAP)     
Ethionamide (ETH)     
p-Amino salicylic acid (PAS)     
Cycloserine (CS)     
Table 3: Comparison of first and second line anti-tuberculous drugs resistance detection offered by web 
based software tools. 
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